L. Thomas

38.3k total citations · 4 hit papers
402 papers, 14.0k citations indexed

About

L. Thomas is a scholar working on Oncology, Epidemiology and Dermatology. According to data from OpenAlex, L. Thomas has authored 402 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 152 papers in Oncology, 111 papers in Epidemiology and 105 papers in Dermatology. Recurrent topics in L. Thomas's work include Cutaneous Melanoma Detection and Management (110 papers), Cutaneous lymphoproliferative disorders research (65 papers) and Nonmelanoma Skin Cancer Studies (54 papers). L. Thomas is often cited by papers focused on Cutaneous Melanoma Detection and Management (110 papers), Cutaneous lymphoproliferative disorders research (65 papers) and Nonmelanoma Skin Cancer Studies (54 papers). L. Thomas collaborates with scholars based in France, United States and Italy. L. Thomas's co-authors include Stéphane Dalle, B. Balme, H. Sherwood Lawrence, John R. David, Salah Al‐Askari, Jean‐Jacques Grob, Claus Garbe, Michele Maio, Alice Phan and Brigitte Dréno and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

L. Thomas

381 papers receiving 13.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma

2014 1.5k citations James Larkin, Paolo A. Ascierto et al. profile →
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

2009 934 citations L. Thomas, Jean‐Jacques Grob et al. The Lancet Oncology profile →
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial

2017 482 citations Caroline Robert, Jean‐Jacques Grob et al. The Lancet Oncology profile →
Delayed Hypersensitivity in vitro. I. The Specificity of Inhibition of Cell Migration by Antigens.

1964 387 citations John R. David, Salah Al‐Askari et al. Immunology profile →

Peers

Countries citing papers authored by L. Thomas

Since Specialization

Citations

This map shows the geographic impact of L. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Thomas more than expected).

Fields of papers citing papers by L. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Thomas. The network helps show where L. Thomas may publish in the future.

Co-authorship network of co-authors of L. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of L. Thomas. A scholar is included among the top collaborators of L. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Thomas. L. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mechanisms of novel Cr(III)/Zr(IV) impregnation and sodium silicates sealing of anodized aluminium alloy for enhancing corrosion performance 2025 ·Surface and Coatings Technology ·(unknown), (unknown), (unknown), L. Thomas, Jérôme Frayret, (unknown), David Sinopoli	1
2	Prediction of melanoma metastasis using dermatoscopy deep features: An international multicenter cohort study. 2024 ·Journal of Clinical Oncology ·Konstantinos Lallas, Panagiota Spyridonos, Harald Kittler, Philipp Tschandl, Giuseppe Argenziano, Renato Marchiori Bakos, Ralph P. Braun, (unknown), Emi Dika, Josep Malvehy, Ashfaq A. Marghoob, Susana Puig, Alon Scope, Wilhelm Stolz, Masaru Tanaka, L. Thomas, Zoé Apalla, Efstratios Vakirlis, Iris Zalaudek, Aimilios Lallas	0
3	Impact of External Magnetic Fields on STT-MRAM: An Application Note 2024 ·SPIRE - Sciences Po Institutional REpository ·B. Diény, S. Aggarwal, V. B. Naik, Sébastien Couet, Thomas Coughlin, Shunsuke Fukami, Kévin Garello, (unknown), Jean Anne C. Incorvia, (unknown), Kyung‐Jin Lee, (unknown), (unknown), (unknown), (unknown), L. Thomas, Weigang Wang, D. C. Worledge	3
4	Impairing hydrolase transport machinery prevents human melanoma metastasis 2024 ·Communications Biology ·(unknown), (unknown), Shivang Parikh, L. Thomas, Roma Parikh, Hananya Vaknine, Ronen Brenner, Francesco Baschieri, Aude Robert, Mehdi Khaled	0
5	Junctional Nevus and Early Melanoma on Sun-Damaged Skin of the Head/Neck: A Clinico-Pathologic Challenge 2023 ·Dermatology Practical & Conceptual ·Elvira Moscarella, Pascale Guitera, Richard A. Scolyer, (unknown), L. Thomas, (unknown), (unknown), Gabriella Brancaccio, Giuseppe Argenziano	1
6	Validation of 3D Knee Kinematics during Gait on Treadmill with an Instrumented Knee Brace 2023 ·Sensors ·(unknown), Raphaël Zory, Olivier Guérin, L. Thomas, Serge S. Colson, Pauline Gerus, Frédéric Chorin	1
7	Dermoscopy of haemosiderotic/aneurysmal dermatofibroma: A morphological study of 110 cases 2022 ·Journal of the European Academy of Dermatology and Venereology ·Pedro Zaballos, (unknown), Álex Llambrich, Josep Malvehy, R. Taberner, (unknown), Giuseppe Argenziano, L. Thomas, Ángel Pizarro, L.J. del Pozo, José Antonio Fernández Avilés, J.M. Martín, Işıl Karaarslan, (unknown), José Bañuls	3
8	5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAF V600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study 2021 ·Clinical Cancer Research ·Paolo A. Ascierto, Brigitte Dréno, James Larkin, Antoni Ribas, Gabriella Liszkay, Michele Maio, Mario Mandalà, Lev Demidov, Daniil Stroyakovskiy, L. Thomas, Luis de la Cruz‐Merino, Victoria Atkinson, Caroline Dutriaux, Claus Garbe, Jessie J. Hsu, (unknown), Haocheng Li, Edward McKenna, Athina Voulgari, Grant A. McArthur	119
9	Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover 2020 ·Cancers ·Célèste Lebbé, Caroline Dutriaux, Thierry Lesimple, (unknown), Joseph Kerger, L. Thomas, B. Guillot, Filippo de Braud, Claus Garbe, Jean‐Jacques Grob, Carmen Loquai, Virginia Ferraresi, Caroline Robert, P. Vasey, Robert M. Conry, Richard Isaacs, Enrique Espinosa, Armin Schueler, (unknown), Brigitte Dréno	32
10	The dynamic molecular landscape of malignant melanomas arising from congenital or common nevi 2019 ·Integrative Molecular Medicine ·(unknown), (unknown), Françoise Descôtes, B. Balme, L. Depaepe, Pierre‐Paul Bringuier, Julie Caramel, L. Thomas, Stéphane Dalle, Jonathan Lopez	1
11	Dermoscopy, Digital Dermoscopy and Other Diagnostic Tools in the Early Detection of Melanoma and Follow-up of High-risk Skin Cancer Patients 2017 ·Acta Dermato Venereologica ·L. Thomas, Susana Puig	37
12	Dermoscopy of tumours arising in naevus sebaceous: a morphological study of 58 cases 2015 ·Journal of the European Academy of Dermatology and Venereology ·Pedro Zaballos, Pedro J. Serrano‐Castro, (unknown), José Bañuls, L. Thomas, Álex Llambrich, (unknown), Aimilios Lallas, Giuseppe Argenziano, Iris Zalaudek, L.J. del Pozo, Claudia Landi, Josep Malvehy	25
13	Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial 2015 ·The Lancet Oncology ·Nicole Basset‐Séguin, Axel Hauschild, Jean‐Jacques Grob, Rainer Kunstfeld, Brigitte Dréno, Laurent Mortier, (unknown), Lisa Licitra, Caroline Dutriaux, L. Thomas, Thomas Jouary, Nicolás Meyer, B. Guillot, Reinhard Dummer, Kate Fife, D. Scott Ernst, Sarah Williams, A. Fittipaldo, Ioannis Xynos, Johan Hansson	170
14	Carcinome basocellulaire tatoué 2013 ·Annales de Dermatologie et de Vénéréologie ·(unknown), L. Thomas, Stéphane Dalle	1
15	Histological features and treatment approach of trichoblastic carcinomas: from a case report to a review of the literature. 2012 ·PubMed ·(unknown), L. Depaepe, A. d’Hombres, B. Balme, L. Thomas, Berardino De Bari	12
16	Coherent precession of propagating domain walls in permalloy nanowires 2007 ·Bulletin of the American Physical Society ·Masamitsu Hayashi, L. Thomas, Charles Rettner, Rai Moriya, S. Parkin	6
17	[Perianal basal cell carcinoma. Apropos of 2 cases]. 1994 ·PubMed ·F. Augey, (unknown), B. Balme, L. Thomas, G Moulin	1
18	Delayed Hypersensitivity ire vitro. I. The Specificity of Inhibition of Cell Migration by Antigens. II. Effect of Sensitive Cells on Normal Cells in the Presence of Antigen. III. The Specificity of Hapten-Protein Conjugates in the Inhibition of Cell Migration. 1964 ·Immunology ·John R. David, Salah Al‐Askari, H. Sherwood Lawrence, L. Thomas	0
19	Delayed Hypersensitivity in vitro. I. The Specificity of Inhibition of Cell Migration by Antigens. breakdown → 1964 ·Immunology ·John R. David, Salah Al‐Askari, H. Sherwood Lawrence, L. Thomas	387
20	Delayed Hypersensitivity ire vitro. I. The Specificity of Inhibition of Cell Migration by Antigens. II. Effect of Sensitive Cells on Normal Cells in the Presence of Antigen. 1964 ·Immunology ·John R. David, Salah Al‐Askari, H. Sherwood Lawrence, L. Thomas	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact